{"title":"Rectal sclerotherapy in children: An author's experience with a sclerosant","authors":"J. Aihole","doi":"10.4103/wjcs.wjcs_26_21","DOIUrl":null,"url":null,"abstract":"Background: Rectal prolapse in children is mainly managed by conservative treatment, especially in those aged <3 years; however, intervention is indicated in cases with persistent and recurrent prolapse that is resistant to conservative treatment. Objective: To determine the efficacy of sclerotherapy using sodium tetradecyl sulphate as a sclerosant in treating rectal prolapse in children. Design: A retrospective chart review. Settings: The study was conducted in a tertiary care pediatric center in Bengaluru, Karnataka. Patients (Material) and Methods: Children aged ≥1 year with persistent rectal prolapse were included in this study, which was conducted from January 2013 to December 2021. The median follow-up period was 1 year. Main Outcome Measure: Resolution of the rectal prolapse. Sample Size: Three hundred and eighty-seven patients. Results: The success rate was 93.5% (43/46) after sclerotherapy treatment. Recurrence was noted in 6.5% of the patients who required a second dose of sclerotherapy or surgery. The median follow-up period was 8 months. There were no remarkable complications or mortality. Conclusion: Rectal sclerotherapy injection is a safe, low-cost procedure with low recurrence rate in children. Limitations: Ours was a retrospective, single-center study, and no control group was utilized. Conflict of Interest: The authors have no conflict of interest to declare.","PeriodicalId":90396,"journal":{"name":"World journal of colorectal surgery","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"World journal of colorectal surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/wjcs.wjcs_26_21","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Rectal prolapse in children is mainly managed by conservative treatment, especially in those aged <3 years; however, intervention is indicated in cases with persistent and recurrent prolapse that is resistant to conservative treatment. Objective: To determine the efficacy of sclerotherapy using sodium tetradecyl sulphate as a sclerosant in treating rectal prolapse in children. Design: A retrospective chart review. Settings: The study was conducted in a tertiary care pediatric center in Bengaluru, Karnataka. Patients (Material) and Methods: Children aged ≥1 year with persistent rectal prolapse were included in this study, which was conducted from January 2013 to December 2021. The median follow-up period was 1 year. Main Outcome Measure: Resolution of the rectal prolapse. Sample Size: Three hundred and eighty-seven patients. Results: The success rate was 93.5% (43/46) after sclerotherapy treatment. Recurrence was noted in 6.5% of the patients who required a second dose of sclerotherapy or surgery. The median follow-up period was 8 months. There were no remarkable complications or mortality. Conclusion: Rectal sclerotherapy injection is a safe, low-cost procedure with low recurrence rate in children. Limitations: Ours was a retrospective, single-center study, and no control group was utilized. Conflict of Interest: The authors have no conflict of interest to declare.